tirzepatide and thyroid medication Tirzepatide

As scientists continue to search for therapies that reverse or halt neurological deterioration, one compound is showing exceptional promise Dihexa

A 2025 FAERS (FDA adverse event reporting system) analysis found a reporting odds ratio of about 1.9 for depression with semaglutide

Backed by a vertically integrated structure and state-of-the-art GMP biologics facility, we accelerate development from discovery to commercial manufacturing - ensuring innovation reaches veterinarians and the pets we love faster and more efficiently

Gastrointestinal effects Nausea is the most commonly reported side effect, especially during the first few weeks and after each dose increase

The REWIND trial with dulaglutide and SUSTAIN-6 with semaglutide also demonstrated cardiovascular benefits

Diagnoses are based on clinical criteria